Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, Simpson JA, Drucker DJ: GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure
As impressive as todays GLP-1 therapies are, I can assure you that what lies in the foreground whether you think of it as the Learjet or Gulfstream equivalent will likely deliver superior performance to what weve been applauding up to this point. In a previous article, I shared insights from the workshop on the pressures created by soaring demand and where the market might go next
How GLP-1 Injections Support Weight Loss GLP-1 injectionssuch as Semaglutide and Liraglutidework differently from older stimulant-based weight loss medications
REWIND Investigators Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Para sa akin imposible kasi mabisyo akong tao
GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation
